EN 
Українська
Polski
Español
Deutsch
日本語
Italiano
Português (BR)
Français
العربية
Nederlands
中文
한국어
हिन्दी
Türkçe
Tiếng Việt
Русский
Bahasa Indonesia
فارسی
বাংলা
ไทย
Filipino
Kiswahili
اردو
Bahasa Melayu
தமிழ்
עברית
Ελληνικά
ਪੰਜਾਬੀ
አማርኛ
မြန်မာဘာသာ
ខ្មែរ
ქართული
नेपाली
Монгол хэл
Հայերեն
සිංහල
ລາວ
Čeština
Română
Magyar
Български
Svenska
Dansk
Suomi
Norsk
Slovenčina
Hrvatski
Српски
Slovenščina
Lietuvių
Latviešu
Eesti
Íslenska
Shqip
Македонски
Bosanski
Malti
Azərbaycanca
Қазақша
O'zbekcha
Тоҷикӣ
КыргызчаContain Antimicrobial Resistance With AI Surveillance
An AI-powered antimicrobial resistance surveillance network integrates genomic signals, coordinates stewardship efforts, and aligns policies to combat the spread of drug-resistant infections.
The speed from sample collection to generating an alert is a crucial component of this system’s effectiveness.
Candidates Supported Through Insights
Participation in data sharing initiatives forms the foundation of this network, allowing for collaborative research and monitoring.
The AI Antimicrobial Resistance Surveillance Network provides a central platform for coordinated action against antimicrobial resistance.
Stewardship Command Hub
This hub utilizes hospital dashboards to track antibiotic usage, delivers prescriber nudges to encourage responsible prescribing, and supports infection control measures alongside supply chain coordination.
The network leverages a global data commons, robust legal frameworks, equitable funding mechanisms, alignment with the World Health Organization (WHO), One Health governance structures, and transparent reporting.
Frequently asked questions
What is the relationship between WHO GLASS, HL7 FHIR, and the One Health framework?
WHO GLASS, HL7 FHIR, and the One Health framework represent interconnected approaches to antimicrobial resistance surveillance, incorporating data standards, collaborative healthcare models, and a holistic understanding of disease transmission.
How long does it take for a country to connect to the network?
Connecting a country to the AI Antimicrobial Resistance Surveillance Network typically takes between 10 and 16 weeks, encompassing the establishment of laboratory infrastructure, data integration, legal agreements, recruitment of personnel, and piloting within local hospitals.
What is the role of laboratory infrastructure within the 10–16 week timeframe?
During the 10-16 week period, establishing laboratory infrastructure is paramount, alongside securing access to relevant data, negotiating legal agreements, training and recruiting staff, and conducting pilot studies in selected hospitals.
What factors contribute to detection speed, coverage, and stewardship adherence within the network?
Detection speed, geographic coverage, and adherence to stewardship programs are all driven by timely data analysis, widespread implementation across healthcare settings, and proactive interventions promoting responsible antibiotic use.
▶ Try it live
Everything above runs in your browser — open Force-Directed Graph and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.